Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
Clinical Rheumatology
|
February 29, 2020
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis
A Deodhar, S D Chakravarty, C Cameron, et al.
Annals of the Rheumatic Diseases
|
April 8, 2022
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure
Atul A Deodhar, Bernard Combe, Ana P Accioly, et al.
Annals of the Rheumatic Diseases
|
August 15, 2013
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol
D van der Heijde, R Fleischmann, J Wollenhaupt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 9, 2016
Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)
Atul A Deodhar, Maxime Dougados, Dominique L Baeten, et al.
The Journal of Rheumatology
|
May 3, 2016
GRAPPA 2015 Research and Education Project Reports
Philip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
The British Journal of Dermatology
|
June 22, 2018
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
R B Warren, K Reich, R G Langley, et al.
BMC Rheumatology
|
September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results
Atul A Deodhar, Philip J Mease, Proton Rahman, et al.
Annals of the Rheumatic Diseases
|
February 15, 2008
Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study
J M Townes, A A Deodhar, E S Laine, et al.
Rheumatology and Therapy
|
March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
Joseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Annals of the Rheumatic Diseases
|
January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
Clinical Rheumatology
|
February 29, 2020
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis
A Deodhar, S D Chakravarty, C Cameron, et al.
Annals of the Rheumatic Diseases
|
April 8, 2022
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure
Atul A Deodhar, Bernard Combe, Ana P Accioly, et al.
Annals of the Rheumatic Diseases
|
August 15, 2013
Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol
D van der Heijde, R Fleischmann, J Wollenhaupt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 9, 2016
Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1)
Atul A Deodhar, Maxime Dougados, Dominique L Baeten, et al.
The Journal of Rheumatology
|
May 3, 2016
GRAPPA 2015 Research and Education Project Reports
Philip J Mease, Philip S Helliwell, Wolf-Henning Boehncke, et al.
The British Journal of Dermatology
|
June 22, 2018
Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database
R B Warren, K Reich, R G Langley, et al.
BMC Rheumatology
|
September 20, 2021
Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results
Atul A Deodhar, Philip J Mease, Proton Rahman, et al.
Annals of the Rheumatic Diseases
|
February 15, 2008
Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study
J M Townes, A A Deodhar, E S Laine, et al.
Rheumatology and Therapy
|
March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
Joseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Annals of the Rheumatic Diseases
|
January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Page
of 10